Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Precision Medicine

Benjamin L. Ebert

M.D., Ph.D.

🏢Dana-Farber Cancer Institute🌐USA

Chair, Department of Medical Oncology

1
Key Papers
2
Key Contributions

👥Biography 个人简介

Benjamin Ebert is a leader in hematologic malignancy research who has made fundamental discoveries about myelodysplastic syndromes and clonal hematopoiesis. His work has characterized the genetic basis of MDS and the clinical implications of clonal hematopoiesis of indeterminate potential (CHIP).

Benjamin Ebert是血液恶性肿瘤研究的领导者,在骨髓增生异常综合征和克隆性造血方面做出了基础性发现。他的工作描述了MDS的遗传基础和不确定潜能克隆性造血(CHIP)的临床意义。

Share:

🧪Research Fields 研究领域

Hematologic Malignancies血液系统恶性肿瘤
MDSMDS
Clonal Hematopoiesis克隆性造血

🎓Key Contributions 主要贡献

MDS Genetics

Characterized genetic basis of myelodysplastic syndromes.

CHIP

Defined clinical implications of clonal hematopoiesis.

Representative Works 代表性著作

[1]

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

New England Journal of Medicine (2014)

CHIP and cancer risk.

📄Data Sources 数据来源

Last updated: 2026-03-05 | All information from publicly available academic sources

关注 Benjamin L. Ebert 的研究动态

Follow Benjamin L. Ebert's research updates

留下邮箱,当我们发布与 Benjamin L. Ebert(Dana-Farber Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment